In August last year the companies began a joint research and development agreement based around iota’s bioelectronic devices in several indications.
Bioelectronics is a field that has been investigated by Google’s life sciences division Verily, which co-founded Galvani Bioelectronics with GlaxoSmithKline in 2016.
The partnership focused on harnessing the body’s electrical signals to treat chronic diseases such as asthma, arthritis and gastrointestinal diseases.
https://pharmaphorum.com/news/astellas-double...-firm-iota